Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-03-03 @ 6:47 PM
Study NCT ID:
NCT01867294
Status:
COMPLETED
Last Update Posted:
2020-01-09
First Post:
2012-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Sponsor:
Academic and Community Cancer Research United
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06-13
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-27
First Submit QC Date:
None
Study First Post Date:
2013-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-22
Results First Submit QC Date:
None
Results First Post Date:
2020-01-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-06
Last Update Post Date:
2020-01-09
Last Update Post Date Type:
ACTUAL